BVE portfolio company FloraWorks has unveiled promising findings from a groundbreaking sleep study on TruCBN™, a proprietary ultra-pure cannabinol-based sleep aid product.
A major milestone in cannabinoid research
Conducted by Radicle Science, the large-scale, double-blind, placebo-controlled trial involved over 1,000 participants. The study showed that a 50 mg dose of TruCBN™ effectively improved sleep quality with minimal side effects, outperforming melatonin in key areas.
“This publication is a testament to our commitment to advancing scientific understanding and clinical validation of cannabinoids,” said Alleh Lindquist, CEO of FloraWorks.
“It marks a major step forward in our efforts to bring TruCBN™ into the mainstream markets as a safe and effective alternative in the fight against sleeplessness.”
Cannabinol (CBN), a non-psychoactive compound derived from cannabis, is gaining attention for its therapeutic potential. In this study, participants reported significant improvements in sleep onset, duration, and quality, positioning TruCBN™ as a natural alternative to mainstream sleep aids.
Disrupting the sleep aid market
FloraWorks’ dedication to cannabinoid research, coupled with its innovative product development, highlights its leadership in the fast-evolving wellness space.
TruCBN™ not only offers a new approach to managing sleep disorders but also addresses a rising consumer demand for natural solutions that avoid dependency on traditional pharmaceuticals. With sleep health being a critical aspect of overall well-being, FloraWorks’ focus on providing effective, cannabinoid-based alternatives has the potential to disrupt the growing sleep aid market.
FloraWorks and BVE’s shared commitment to innovation
“FloraWorks’ progress in cannabinoid-based sleep solutions reinforces our confidence in the potential of cannabinoids to play a crucial role in the future of wellness,” said Ross O’Brien, Founder & Managing Partner at BVE.
“As part of BVE’s investment portfolio, FloraWorks exemplifies the kind of innovation we support — companies with a focus on transformative health solutions backed by rigorous science. This FloraWorks study is a testament to its commitment to evidence-based products, and it opens up new opportunities for broader applications of CBN in treating insomnia and other sleep disorders.”
